Skip to main content

Table 9 Duration of antibiotic use in the IFNα1b group and the control group

From: Efficacy and safety of aerosol inhalation of recombinant human interferon α1b (IFNα1b) injection for noninfluenza viral pneumonia, a multicenter, randomized, double-blind, placebo-controlled trial

 FASPPS
ItemIFNα1b GroupControl GroupIFNα1b GroupControl Group
n (Missing)140 (24)138 (22)122 (21)131 (20)
Mean (SD)7.84 (3.50)7.99 (3.78)7.83 (3.25)7.95 (3.83)
Median8888
Q1, Q35.0, 9.35.8, 10.36.0, 9.05.0, 10.5
Min, Max1,161,161,161,16
95% CI7.20, 8.497.30, 8.697.19, 8.477.24,8.67
StatisticsWilcoxon rank sum test6523Wilcoxon rank sum test5416
P0.688 0.670